- Home
- Publications
- Publication Search
- Publication Details
Title
Origin and Therapies of Osteosarcoma
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 14, Pages 3503
Publisher
MDPI AG
Online
2022-07-19
DOI
10.3390/cancers14143503
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent and Ongoing Research into Metastatic Osteosarcoma Treatments
- (2022) Michael A. Harris et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Osteosarcoma: a review of current and future therapeutic approaches
- (2021) Xin Zhao et al. Biomedical Engineering Online
- First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors
- (2021) George D. Demetri et al. CLINICAL CANCER RESEARCH
- Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release
- (2021) Jeong A Park et al. Journal for ImmunoTherapy of Cancer
- Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma
- (2021) Jaline Broqueza et al. Cancers
- Antibody Conjugates for Sarcoma Therapy: How Far along Are We?
- (2021) Letizia Polito et al. Biomedicines
- New Horizons in the Treatment of Osteosarcoma
- (2021) Paul S. Meltzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis
- (2021) Sarah Morice et al. Frontiers in Oncology
- Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆
- (2021) N. Gaspar et al. ESMO Open
- Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial
- (2020) Antoine Italiano et al. LANCET ONCOLOGY
- Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421): A report from the Children’s Oncology Group.
- (2020) Pooja Hingorani et al. JOURNAL OF CLINICAL ONCOLOGY
- OSTPDL1: A phase II study of avelumab, a monoclonal antibody targeting programmed death-ligand 1 (PD-L1) in adolescent and young adult patients with recurrent or progressive osteosarcoma.
- (2020) Michael William Bishop et al. JOURNAL OF CLINICAL ONCOLOGY
- Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?
- (2020) Sarah Morice et al. Cancers
- The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
- (2020) Heinrich Kovar et al. Cells
- Osteosarcoma
- (2020) Bree R. Eaton et al. PEDIATRIC BLOOD & CANCER
- Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
- (2020) Bassel Nazha et al. Frontiers in Oncology
- Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?
- (2020) Zhichao Tian et al. Frontiers in Oncology
- The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
- (2020) Sarah Morice et al. Cancers
- MicroRNA-876-5p inhibits cell proliferation, migration and invasion by targeting c-Met in osteosarcoma
- (2019) Weixin Xie et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Hypoxia promotes osteosarcoma cell proliferation and migration through enhancing platelet-derived growth factor-BB/platelet-derived growth factor receptor-β axis
- (2019) Dan Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Editor's Note: Inhibition of Platelet-derived Growth Factor–mediated Proliferation of Osteosarcoma Cells by the Novel Tyrosine Kinase Inhibitor STI571
- (2019) Eric C. McGary et al. CLINICAL CANCER RESEARCH
- Is there a benefit of addition docetaxel, abiraterone, celecoxib or zoledronic acid in initial treatments for patients older than 70 years with hormone sensitive advanced prostate cancer? A Meta-analysis
- (2019) Thierry Landre et al. Clinical Genitourinary Cancer
- Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
- (2019) Lara E. Davis et al. JOURNAL OF CLINICAL ONCOLOGY
- Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling
- (2019) Qiang Zhou et al. JOURNAL OF DRUG TARGETING
- Assessment of resection margins in bone sarcoma treated by neoadjuvant chemotherapy: Literature review and guidelines of the bone group (GROUPOS) of the French sarcoma group and bone tumor study group (GSF-GETO/RESOS)
- (2019) Anne Gomez-Brouchet et al. Orthopaedics & Traumatology-Surgery & Research
- TP53 in bone and soft tissue sarcomas
- (2019) Elizabeth Thoenen et al. PHARMACOLOGY & THERAPEUTICS
- Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors
- (2019) Sharayu Karkare et al. Scientific Reports
- ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
- (2019) Cinzia Zucchini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft
- (2018) Sara R. Martins-Neves et al. CANCER LETTERS
- LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
- (2018) James W. Purcell et al. CANCER RESEARCH
- The anti-tumor effect of RANKL inhibition in malignant solid tumors – A systematic review
- (2018) A.F. de Groot et al. CANCER TREATMENT REVIEWS
- Evaluation of acute and chronic ecotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and UV treated samples
- (2018) Chiara Russo et al. ENVIRONMENTAL POLLUTION
- Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study
- (2018) Nathalie Gaspar et al. EUROPEAN JOURNAL OF CANCER
- Advances in studies of tyrosine kinase inhibitors and their acquired resistance
- (2018) Qinlian Jiao et al. Molecular Cancer
- Immunotherapy for osteosarcoma: Where do we go from here?
- (2018) Mary F. Wedekind et al. PEDIATRIC BLOOD & CANCER
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- LRRC15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/nuclear translocation
- (2018) Yuejun Wang et al. Stem Cell Research & Therapy
- Understanding osteosarcomas
- (2018) Emily Simpson et al. JAAPA-Journal of the American Academy of Physician Assistants
- Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.
- (2018) Giulia Mesiano et al. OncoImmunology
- Role of key players in paradigm shifts of prostate cancer bone metastasis
- (2018) Ayesha Sohail et al. Cancer Management and Research
- The Osteoclast in Bone Metastasis: Player and Target
- (2018) Antonio Maurizi et al. Cancers
- B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
- (2018) Peixin Dong et al. Frontiers in Oncology
- Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma
- (2018) Yang W. Shao et al. ONCOGENE
- PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases
- (2018) Yanmei Yang et al. International Journal of Endocrinology
- Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
- (2018) Florence Duffaud et al. LANCET ONCOLOGY
- A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy
- (2017) Fariba Navid et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of clinical process in osteosarcoma patients treated with chemotherapy including cisplatin, adriamycin, ifosfamide, and etoposide and determination of the treatment sequels in a long-term 11-year follow-up
- (2017) Mozaffar Aznab et al. Journal of Cancer Research and Therapeutics
- Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Sukhbinder Dhesy-Thind et al. JOURNAL OF CLINICAL ONCOLOGY
- C-myc expression in adrenocortical tumours
- (2017) Mirkka Pennanen et al. JOURNAL OF CLINICAL PATHOLOGY
- The role of c-Myc-RBM38 loop in the growth suppression in breast cancer
- (2017) Xiao-Xia Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Reconstruction Following Tumor Resections in Skeletally Immature Patients
- (2017) Adam S. Levin et al. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- (2017) Hussein A Tawbi et al. LANCET ONCOLOGY
- Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2
- (2017) Cristina Meazza et al. MEDICAL ONCOLOGY
- Denosumab: Current Use in the Treatment of Primary Bone Tumors
- (2017) Olga D. Savvidou et al. ORTHOPEDICS
- Pazopanib for second recurrence of osteosarcoma in pediatric patients
- (2017) Katsutsugu Umeda et al. PEDIATRICS INTERNATIONAL
- Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
- (2017) Lars Wagner et al. OncoTargets and Therapy
- Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma
- (2017) Tomohiro Fujiwara et al. Oncotarget
- Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1
- (2017) Emanuela Palmerini et al. Oncotarget
- miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22
- (2017) Xiaodong Li et al. MEDICAL SCIENCE MONITOR
- Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone
- (2017) Gabriel N. Hortobagyi et al. JAMA Oncology
- Knockdown of AXL Receptor Tyrosine Kinase in Osteosarcoma Cells Leads to Decreased Proliferation and Increased Apoptosis
- (2017) Y. Zhang et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- The Role and Clinical Significance of Yes-Associated Protein 1 in Human Osteosarcoma
- (2017) Y-H. Zhang et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations
- (2016) M. Bousquet et al. ANNALS OF ONCOLOGY
- GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
- (2016) Mihwa Kim et al. Autophagy
- Calcium-Sensing Receptor Promotes Breast Cancer by Stimulating Intracrine Actions of Parathyroid Hormone–Related Protein
- (2016) Wonnam Kim et al. CANCER RESEARCH
- Future directions in the treatment of osteosarcoma
- (2016) Michael W. Bishop et al. CURRENT OPINION IN PEDIATRICS
- Drugs in early clinical development for the treatment of osteosarcoma
- (2016) Marie-Françoise Heymann et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling
- (2016) Xian Lin et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial
- (2016) Sophie Piperno-Neumann et al. LANCET ONCOLOGY
- The pharmacogenomics of osteosarcoma
- (2016) M Serra et al. PHARMACOGENOMICS JOURNAL
- Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma
- (2016) Eun Ho Kim et al. Oncotarget
- Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
- (2016) Corinne Bouvier et al. Oncotarget
- TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
- (2016) Audrey Lamora et al. Journal of Clinical Medicine
- Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
- (2016) Sara Westrøm et al. PLoS One
- Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
- (2016) Pratistha Koirala et al. Scientific Reports
- Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression
- (2015) B. Ory et al. CLINICAL CANCER RESEARCH
- Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF- B Pathway
- (2015) D. Liao et al. CLINICAL CANCER RESEARCH
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
- (2015) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- An update on chemotherapy for osteosarcoma
- (2015) Stefano Ferrari et al. EXPERT OPINION ON PHARMACOTHERAPY
- Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
- (2015) Stefan S. Bielack et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions
- (2015) Danielle M. Lussier et al. JOURNAL OF IMMUNOTHERAPY
- Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes
- (2015) Karin Grannas et al. JOURNAL OF MOLECULAR BIOLOGY
- Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
- (2015) Giovanni Grignani et al. LANCET ONCOLOGY
- Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
- (2015) D Weekes et al. ONCOGENE
- Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
- (2015) Cindy L. Schwartz et al. PEDIATRIC BLOOD & CANCER
- Prospective immunotherapies in childhood sarcomas: PD1/PDL1 blockade in combination with tumor vaccines
- (2015) Theodore S. Nowicki et al. PEDIATRIC RESEARCH
- Overcoming T cell exhaustion in infection and cancer
- (2015) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63
- (2015) Xin Li et al. TUMOR BIOLOGY
- Receptor activator of nuclear factor κB expression is a prognostic factor in human osteosarcoma
- (2015) KLEMENS TRIEB et al. Oncology Letters
- Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
- (2015) Michal Kovac et al. Nature Communications
- ATRX represses alternative lengthening of telomeres
- (2015) Christine E. Napier et al. Oncotarget
- Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis
- (2015) Miyoung Lee et al. Oncotarget
- The Functional Role of PMP22 Gene in the Proliferation and Invasion of Osteosarcoma
- (2015) Zhiping Chen MEDICAL SCIENCE MONITOR
- The Prognostic Significance of Src and p-Src Expression in Patients with Osteosarcoma
- (2015) Yuanlong Xie MEDICAL SCIENCE MONITOR
- Increased CTLA-4+ T cells and an increased ratio of monocytes with loss of class II (CD14+ HLA-DRlo/neg) found in aggressive pediatric sarcoma patients
- (2015) Pooja Hingorani et al. Journal for ImmunoTherapy of Cancer
- CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic
- (2015) Margaret K. Callahan et al. Frontiers in Oncology
- Immunotherapy of Childhood Sarcomas
- (2015) Stephen S. Roberts et al. Frontiers in Oncology
- Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: Current hurdles and future perspectives
- (2014) Emmy D.G. Fleuren et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Sarcoma classification: An update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone
- (2014) Leona A. Doyle CANCER
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance
- (2014) Alberto S. Pappo et al. CANCER
- Platelets promote osteosarcoma cell growth through activation of the platelet-derived growth factor receptor-Akt signaling axis
- (2014) Satoshi Takagi et al. CANCER SCIENCE
- Classification, imaging, biopsy and staging of osteosarcoma
- (2014) ZileSingh Kundu Indian Journal of Orthopaedics
- Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
- (2014) Bing-Jia Chen et al. International Journal of Biological Sciences
- Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL
- (2014) Tetsuro Ohba et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents
- (2014) Shoji Shimose et al. JOURNAL OF ORTHOPAEDIC SCIENCE
- 6-Thioguanine: A Drug With Unrealized Potential for Cancer Therapy
- (2014) Pashna N. Munshi et al. ONCOLOGIST
- Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo
- (2014) ZHI YANG et al. ONCOLOGY REPORTS
- Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
- (2014) Bérengère Gobin et al. PLoS One
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
- (2014) Jennifer A. Perry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle
- (2014) François Lamoureux et al. Nature Communications
- Structuring osteosarcoma knowledge: an osteosarcoma-gene association database based on literature mining and manual annotation
- (2014) Kathrin Poos et al. Database-The Journal of Biological Databases and Curation
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
- (2014) Xiang Chen et al. Cell Reports
- Programmed Cell Death Ligand 1 Expression in Osteosarcoma
- (2014) J. K. Shen et al. Cancer Immunology Research
- Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
- (2014) M. Fernanda Amary et al. Cancer Medicine
- Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients
- (2013) Ju Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1
- (2013) Xin Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas
- (2013) D. Sangiolo et al. CANCER RESEARCH
- Osteosarcoma treatment – Where do we stand? A state of the art review
- (2013) Anja Luetke et al. CANCER TREATMENT REVIEWS
- Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
- (2013) L. Gammaitoni et al. CLINICAL CANCER RESEARCH
- Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy
- (2013) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide association study identifies two susceptibility loci for osteosarcoma
- (2013) Sharon A Savage et al. NATURE GENETICS
- LncRNA loc285194 is a p53-regulated tumor suppressor
- (2013) Qian Liu et al. NUCLEIC ACIDS RESEARCH
- Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression
- (2013) L H Chan et al. ONCOGENE
- WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition
- (2013) Vickie Y. Jo et al. PATHOLOGY
- Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group
- (2013) Brenda Weigel et al. PEDIATRIC BLOOD & CANCER
- Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas
- (2013) Jung Ryul Kim et al. PLoS One
- Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers
- (2013) M. Pourdehnad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- IGF-1R as an anti-cancer target--trials and tribulations
- (2013) Helen X. Chen et al. Chinese Journal of Cancer
- Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K–Akt signaling
- (2012) Kelai Wang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade
- (2012) Makiko Fujii et al. CELL CYCLE
- Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art
- (2012) M. Clemons et al. Current Oncology
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- How Much of a Good Thing? What Duration for Interferon Alfa-2b Adjuvant Therapy?
- (2012) Ahmad A. Tarhini et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
- (2012) David Ebb et al. JOURNAL OF CLINICAL ONCOLOGY
- 153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients
- (2011) M. Berger et al. ANNALS OF ONCOLOGY
- A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study
- (2011) G. Grignani et al. ANNALS OF ONCOLOGY
- Cell surface receptor expression patterns in osteosarcoma
- (2011) Sheref E. Hassan et al. CANCER
- Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
- (2011) Jakob K. Anninga et al. EUROPEAN JOURNAL OF CANCER
- Latest developments in limb-salvage surgery in osteosarcoma
- (2011) Karan S Mangat et al. Expert Review of Anticancer Therapy
- The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model
- (2011) Erik R Sampson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium
- (2011) Richard Aplenc et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
- (2011) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
- (2011) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- RANK Is Expressed in Metastatic Melanoma and Highly Upregulated on Melanoma-Initiating Cells
- (2011) Verena Kupas et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma
- (2011) Yin-He Wang et al. JOURNAL OF SURGICAL ONCOLOGY
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- Osteosarcoma
- (2010) J. Ritter et al. ANNALS OF ONCOLOGY
- Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy
- (2010) Bekim Sadikovic et al. BMC CANCER
- Recurrent Focal Copy-Number Changes and Loss of Heterozygosity Implicate Two Noncoding RNAs and One Tumor Suppressor Gene at Chromosome 3q13.31 in Osteosarcoma
- (2010) I. Pasic et al. CANCER RESEARCH
- Regulation of the p14ARF promoter by DNA methylation
- (2010) Vinay Badal et al. CELL CYCLE
- Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma
- (2010) J. Smida et al. CLINICAL CANCER RESEARCH
- Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
- (2010) E. L. Mayer et al. CLINICAL CANCER RESEARCH
- In Brief: Classifications in Brief: Enneking Classification: Benign and Malignant Tumors of the Musculoskeletal System
- (2010) Muhammad Umar Jawad et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Pediatric osteogenic sarcoma
- (2010) Han Jo Kim et al. CURRENT OPINION IN PEDIATRICS
- Analysis of Segmental Duplications, Mouse Genome Synteny and Recurrent Cancer-Associated Amplicons in Human Chromosome 6p21–p12
- (2010) J.W. Martin et al. CYTOGENETIC AND GENOME RESEARCH
- Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling
- (2010) T. van Harn et al. GENES & DEVELOPMENT
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response
- (2010) M B Weiss et al. ONCOGENE
- RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma
- (2010) Jun Ah Lee et al. PEDIATRIC BLOOD & CANCER
- Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence
- (2010) Pierre Perrot et al. PLoS One
- Biology, diagnosis and treatment of canine appendicular osteosarcoma: Similarities and differences with human osteosarcoma
- (2010) Emanuela Morello et al. VETERINARY JOURNAL
- Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model
- (2009) Ines J Marques et al. BMC CANCER
- Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma
- (2009) Alexander J. Chou et al. CANCER
- Inhibition of Src Phosphorylation Alters Metastatic Potential of Osteosarcoma In vitro but not In vivo
- (2009) P. Hingorani et al. CLINICAL CANCER RESEARCH
- International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
- (2009) Lisa Mirabello et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Time to Resumption of Chemotherapy After Definitive Surgery on Prognosis for Non-Metastatic Osteosarcoma
- (2009) Hamayun Imran et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
- (2009) Maya Kansara et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
- (2009) Rashmi Chugh et al. JOURNAL OF CLINICAL ONCOLOGY
- mTOR/p70S6K Signal transduction pathway contributes to osteosarcoma progression and patients’ prognosis
- (2009) Quan Zhou et al. MEDICAL ONCOLOGY
- Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
- (2009) Ymera Pignochino et al. Molecular Cancer
- Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
- (2009) B Song et al. ONCOGENE
- Clinically relevant dose of zoledronic acid inhibits spontaneous lung metastasis in a murine osteosarcoma model
- (2008) Kazutaka Koto et al. CANCER LETTERS
- Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
- (2008) C. R. Walkley et al. GENES & DEVELOPMENT
- A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer
- (2008) Hedy Lee Kindler et al. INVESTIGATIONAL NEW DRUGS
- Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
- (2008) Paul A. Meyers et al. JOURNAL OF CLINICAL ONCOLOGY
- Cell Cycle Regulator Gene CDC5L, a Potential Target for 6p12-p21 Amplicon in Osteosarcoma
- (2008) X.-Y. Lu et al. MOLECULAR CANCER RESEARCH
- Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway
- (2008) T. Akiyama et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started